STOCK TITAN

Neptune Wellness Solutions Inc. Announces US$35 Million Private Placement

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Neptune Wellness Solutions has announced a private placement totaling approximately US$35 million through the sale of 16,203,700 common shares and 10,532,401 warrants at US$2.16 per share. The funds will be utilized for purchase order fulfillment, working capital, and general corporate purposes. The offering is expected to close around October 22, 2020, pending regulatory approvals. A.G.P./Alliance Global Partners is the sole placement agent. The shares will be sold under U.S. securities exemptions and will not be available for resale without registration.

Positive
  • Successful private placement of approximately US$35 million.
  • Expected use of proceeds for fulfilling purchase orders and working capital.
Negative
  • None.

LAVAL, QC, Oct. 20, 2020 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (TSX: NEPT) (NASDAQ: NEPT), a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, today announced it has entered into definitive agreements with certain US healthcare focused institutional investors for a private placement of 16,203,700 common shares and 10,532,401 warrants to purchase 10,532,401 common shares at an offering price of US$2.16 per share for gross proceeds of approximately US$35 million before deducting fees and other estimated offering expenses (the "Private Placement").

The Company expects to use the net proceeds from the Private Placement for purchase order fulfilment, working capital and other general corporate purposes. The Private Placement is expected to close on or about October 22, 2020, subject to the satisfaction of customary closing conditions and the receipt of regulatory approvals, including the approval of the Toronto Stock Exchange.

A.G.P./Alliance Global Partners is acting as sole placement agent for the Private Placement.

The Private Placement is being made in the United States pursuant to the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission (SEC) and the securities being sold in the Private Placement may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The Company has agreed to file a prospectus supplement to its existing registration statement on Form F-10 (File No. 333-229631) with the SEC covering the resale of the common shares issued in the Private Placement, as well as the common shares issuable upon exercise of the warrants issued in the Private Placement.

This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

ABOUT NEPTUNE WELLNESS SOLUTIONS INC.

Neptune Wellness Solutions is a unique global health and wellness company that is changing consumer habits through the creation and distribution of environmentally friendly, ethical and innovative consumer product goods.  Neptune's simultaneous focus on B2C and B2B customer-oriented brand development provides the Company with international reach and scale from its owned and operated facilities that extract and create product formulation, all the way to the sales floor at top global retailers.

Underpinned by a disruptive spirit, Neptune's diversified and fully integrated business model focuses on natural, plant-based, sustainable and purpose-driven lifestyle brands and the use of cannabinoids in household products to make them safer, healthier and more effective. Its portfolio includes emerging brands such as Forest Remedies™, Ocean Remedies™, Neptune Wellness™, Mood Ring™, and OCEANO3™, which are poised for rapid growth and expansion.

Backed with a cost-efficient manufacturing and supply chain infrastructure that can be scaled up and down or into adjacent product categories to identify new innovation opportunities, Neptune quickly adapts to consumer preferences and demand, and is bringing its products as well as other Fortune 100 brands to market through strategic distribution partnerships, mass retail partners and e-commerce channels. Neptune is committed to its core mission of redefining health and wellness and helping humanity thrive by providing sustainable consumer focused solutions.  For additional information, please visit: https://neptunecorp.com/ 

Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENTS:

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", "projects", "anticipates", "will", "should" or "plans" to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Neptune's latest Annual Information Form (the "AIF"), which also forms part of Neptune's latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.shtml and on the investor section of Neptune's website at www.neptunecorp.com. All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein include, without limitation, statements about the expected closing of the Private Placement; anticipated use of proceeds of the Private Placement; and other risks and uncertainties that are described from time to time in Neptune's public securities filings with the Securities and Exchange Commission and the Canadian securities commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under "Risk Factors". Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/neptune-wellness-solutions-inc-announces-us35-million-private-placement-301156206.html

SOURCE Neptune Wellness Solutions Inc.

FAQ

What is the purpose of the US$35 million private placement by Neptune (NEPT)?

The private placement aims to raise funds for purchase order fulfillment, working capital, and other general corporate purposes.

When is the expected closing date of Neptune's private placement?

The private placement is expected to close on or about October 22, 2020.

How many shares and warrants is Neptune (NEPT) offering in the private placement?

Neptune is offering 16,203,700 common shares and 10,532,401 warrants.

What is the offering price per share in Neptune's private placement?

The offering price is US$2.16 per share.

Who is the placement agent for Neptune's private placement?

A.G.P./Alliance Global Partners is acting as the sole placement agent.

Neptune Wellness Solutions Inc

NASDAQ:NEPT

NEPT Rankings

NEPT Latest News

NEPT Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Laval